Skip to content

SCHEDULE 13D/AAccepted Jan 21, 6:38 PM ET

OnKure Therapeutics, Inc. SCHEDULE 13D/A

RiverVest Venture Fund III, L.P.

Accepted (ET)

6:38 PM

Jan 21, 2025

Filed

Jan 21, 2025

Documents

1

Size

29.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.